TABLE 1. Licensed and available* meningococcal vaccines — United States, 2020.
| Vaccine product | Manufacturer | Trade name | Age group | Year licensed |
|---|---|---|---|---|
|
Conjugate (serogroups A, C, W, and Y)
| ||||
|
MenACWY-D
|
Sanofi Pasteur |
Menactra† |
9 mos–55 yrs |
2005 |
|
MenACWY-CRM
|
GlaxoSmithKline |
Menveo§ |
2 mos–55 yrs |
2010 |
|
MenACWY-TT
|
Sanofi Pasteur |
MenQuadfi¶ |
≥2 yrs |
2020 |
|
Protein based (directed at serogroup B)
| ||||
|
MenB-FHbp
|
Pfizer |
Trumenba** |
10–25 yrs |
2014 |
| MenB-4C | GlaxoSmithKline | Bexsero†† | 10–25 yrs | 2015 |
Abbreviations: MenACWY-CRM = meningococcal groups A, C, W, and Y oligosaccharide diphtheria CRM197 conjugate vaccine; MenACWY-D = meningococcal groups A, C, W, and Y polysaccharide diphtheria toxoid conjugate vaccine; MenACWY-TT = meningococcal groups A, C, W, and Y polysaccharide tetanus toxoid conjugate vaccine; MenB-4C = four-component meningococcal group B vaccine; MenB-FHbp = meningococcal group B factor H binding protein vaccine.
* Two licensed meningococcal vaccines are no longer available in the United States (Menomune – A/C/Y/W-135 [Source: Menomune – A/C/Y/W-135. Package insert. Swiftwater, PA: Sanofi Pasteur; 2016. https://www.fda.gov/media/83562/download] and MenHibrix [Source: MenHibRix. Package insert. Rixensart, Belgium: GlaxoSmithKline Biologicals; 2012. https://www.fda.gov/media/83688/download]).
† Source: Menactra. Package insert. Swiftwater, PA: Sanofi Pasteur; 2018. https://www.fda.gov/media/75619/download
§ Source: Menveo. Package insert. Sovicille, Italy: GlaxoSmithKline Vaccines; 2019. https://www.fda.gov/media/78514/download
¶ Source: MenQuadfi. Package insert Swiftwater, PA: Sanofi Pasteur; 2020. https://www.fda.gov/media/137306/download
** Source: Trumenba. Package insert. Philadelphia, PA: Pfizer; 2018. https://www.fda.gov/media/89936/download
†† Source: Bexsero. Package insert. Sovicille, Italy: GlaxoSmithKline Vaccines; 2018. https://www.fda.gov/media/90996/download